WO2019027239A3 - Composition for preventing hair loss or promoting hair growth - Google Patents
Composition for preventing hair loss or promoting hair growth Download PDFInfo
- Publication number
- WO2019027239A3 WO2019027239A3 PCT/KR2018/008710 KR2018008710W WO2019027239A3 WO 2019027239 A3 WO2019027239 A3 WO 2019027239A3 KR 2018008710 W KR2018008710 W KR 2018008710W WO 2019027239 A3 WO2019027239 A3 WO 2019027239A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extract
- composition
- daniellii
- quercitrin
- evodia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a composition for preventing hair loss or promoting hair growth, the composition comprising: an indirubin derivative; and at least one selected from the group consisting of an Evodia daniellii extract, a Persicaria hydropiper extract, a Hovenia dulcis extract, methyl vanilate, hesperidin, and quercitrin. Furthermore, the at least one selected from the group consisting of an Evodia daniellii extract, a Persicaria hydropiper extract, a Hovenia dulcis extract, methyl vanilate, hesperidin, and quercitrin of the present invention is a natural substance-derived composition and has little toxicity to cells, and the indirubin derivative is a stable compound that has been found to have little toxicity to the human body, so that, unlike a conventional steroid drug, the use thereof as a mixture has an advantage of not showing side effects on the human body.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201880060269.5A CN111093620B (en) | 2017-08-01 | 2018-07-31 | Composition for preventing hair loss or promoting hair growth |
US16/635,275 US11154566B2 (en) | 2017-08-01 | 2018-07-31 | Composition for preventing hair loss or promoting hair growth |
EP18840790.2A EP3662891B1 (en) | 2017-08-01 | 2018-07-31 | Composition for preventing hair loss or promoting hair growth |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170097539 | 2017-08-01 | ||
KR10-2017-0097539 | 2017-08-01 | ||
KR1020180087096A KR102112736B1 (en) | 2017-08-01 | 2018-07-26 | composition for preventing of hair loss or promoting hair growth |
KR10-2018-0087096 | 2018-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019027239A2 WO2019027239A2 (en) | 2019-02-07 |
WO2019027239A3 true WO2019027239A3 (en) | 2019-03-28 |
Family
ID=65234050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/008710 WO2019027239A2 (en) | 2017-08-01 | 2018-07-31 | Composition for preventing hair loss or promoting hair growth |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2019027239A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220054854A (en) | 2019-11-04 | 2022-05-03 | 주식회사 씨케이리제온 | Compositions and methods for inhibiting and/or treating neurodegenerative diseases and/or clinical conditions thereof |
CN113425636B (en) * | 2021-05-21 | 2023-01-31 | 广州德谷个人护理用品有限公司 | Preparation method of tea bran flavone and application of tea bran flavone in anti-hair loss product |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110130711A1 (en) * | 2009-11-19 | 2011-06-02 | Follica, Inc. | Hair growth treatment |
WO2015005603A1 (en) * | 2013-07-11 | 2015-01-15 | Industry-Academic Cooperation Foundation, Yonsei University | Small molecule, indirubin-3-oxime, for prevention and treatment of bone disease |
JP2016539987A (en) * | 2013-12-13 | 2016-12-22 | レスターシー エルエルシイRestorsea, Llc | Exfoliating hair retention promoting formulation |
KR20170030175A (en) * | 2015-09-09 | 2017-03-17 | 강원대학교산학협력단 | Ready-to-use adjuvant composition for intranasal immunization based on microemulsion |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101168051B1 (en) | 2008-09-08 | 2012-07-24 | 김우경 | Pharmaceutical Compositions for Treating or Preventing Ophthalmic or Skin Disease Comprising Curcumin as an Active Ingredient |
-
2018
- 2018-07-31 WO PCT/KR2018/008710 patent/WO2019027239A2/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110130711A1 (en) * | 2009-11-19 | 2011-06-02 | Follica, Inc. | Hair growth treatment |
WO2015005603A1 (en) * | 2013-07-11 | 2015-01-15 | Industry-Academic Cooperation Foundation, Yonsei University | Small molecule, indirubin-3-oxime, for prevention and treatment of bone disease |
JP2016539987A (en) * | 2013-12-13 | 2016-12-22 | レスターシー エルエルシイRestorsea, Llc | Exfoliating hair retention promoting formulation |
KR20170030175A (en) * | 2015-09-09 | 2017-03-17 | 강원대학교산학협력단 | Ready-to-use adjuvant composition for intranasal immunization based on microemulsion |
Also Published As
Publication number | Publication date |
---|---|
WO2019027239A2 (en) | 2019-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000887A (en) | Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer. | |
MX2019013954A (en) | Covalent inhibitors of kras. | |
MX2021005924A (en) | Compounds and methods of use thereof for treatment of cancer. | |
MX2018000777A (en) | Substituted quinazoline compounds and their use as inhibitors of g12c mutant kras, hras and/or nras proteins. | |
MX2018005967A (en) | 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof. | |
PH12021551257A1 (en) | Cyclic pantetheine derivatives and uses thereof | |
CL2021002165A1 (en) | New derivatives of heterocyclic compounds and their use | |
WO2018201167A3 (en) | Propionic acid derivatives and methods of use thereof | |
MX2022001697A (en) | Pyrrolopyridine-aniline compounds for treatment of dermal disorders. | |
PH12020550133A1 (en) | Crystal forms of immunomodulators | |
EP4327880A3 (en) | Solid state form of ribociclib succinate | |
MX2020005942A (en) | Oral thin film with high active agent loading. | |
MX2021015543A (en) | Pyrimidine derivative inhibiting growth of cancer cell and medicinal use thereof. | |
CR20220160A (en) | Azole-fused pyridazin-3(2h)-one derivatives | |
SA520411635B1 (en) | Fused Ring Derivative as A2A Receptor Inhibitor | |
MX2020011986A (en) | Compositions comprising glucose and hemicellulose and their use. | |
CR20220216A (en) | Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases | |
WO2019027239A3 (en) | Composition for preventing hair loss or promoting hair growth | |
BR112021011325A2 (en) | Rapamycin derivatives | |
MX2020007985A (en) | Inhibiting the transient receptor potential a1 ion channel. | |
MX2019010101A (en) | Compositions and methods for promoting hair growth with mpc1 inhibitors. | |
MX2021012105A (en) | Pyrrole compounds. | |
AU2019375825A8 (en) | Macrocyclic tyrosine kinase inhibitor and uses thereof | |
PH12021550617A1 (en) | Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application | |
MX2021003739A (en) | Quinolino-pyrrolidin-2-one derivative and application thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18840790 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2018840790 Country of ref document: EP Effective date: 20200302 |